Autopsy report · NCT03340103

Early Administration of the Lutein/Zeaxanthin in Premature Newborns

“Recruitment was not possible”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Sooft Italia

Sponsor type

Industry

Conditions

Antioxidant Role of the Lutein in Preterm Newborn

Interventions

LUTEIN ofta 0,5 gocce; Placebo

Participants

0

Sites

4

Countries

Italy

Trials that died the same way

• Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
  “Recruiting was not possible” (89% match in meaning)
• Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years
  “Recruitment impossible” (86% match in meaning)
• Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
  “Recruitment insufficient” (80% match in meaning)
• Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).
  “insufficient recruitment” (79% match in meaning)
• Clinical Management of Neuropathic Pain With Ramelteon
  “Recruitment did not accrue as expected.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.